NewsReal Estate28/07/2020
CRISPR signs full-building lease at The 105
Tishman Speyer →Breakthrough announced a full-building lease with CRISPR Therapeutics at The 105 in Boston. The source says the property was acquired in July 2019; no day or investment in CRISPR is inferred.